Document is current
Any future updates will be listed below
-
Authors
Meyers, Lauren M.
Gutiérrez, Andres H.
Boyle, Christine M.
Terry, Frances
McGonnigal, Bethany G.
Salazar, Andres
Princiotta, Michael F.
Martin, Wiliam D.
De Groot, Anne S.
Moise, Leonard https://orcid.org/0000-0002-4410-865X
- License Information
-
More Information
Article History
Received: 20 January 2021
Accepted: 1 April 2021
First Online: 13 May 2021
Competing interests
: A.S.D.G. and W.D.M. are senior officers and shareholders, and L.M.M., A.H.G., C.M.B., F.T., B.G.M., and L.M. are employees of EpiVax, Inc., a privately owned biotechnology company located in Providence, RI. M.F.P. is an employee of EpiVax Therapeutics, Inc. Both EpiVax and EpiVax Therapeutics are developing COVID-19 vaccines. These authors acknowledge that there is a potential conflict of interest related to their relationship with EpiVax and attest that the work contained in this research report is free of any bias that might be associated with the commercial goals of the company. A.S. is a senior officer at Oncovir, Inc. Oncovir is developing a COVID-19 therapy. He acknowledges that there is a potential conflict of interest related to his relationship with Oncovir and attests that the work contained in this research report is free of any bias that might be associated with the commercial goals of the company.
